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Neuroendocrine tumor (NET) in adenoma of the gastrointestinal tract is a rare mixed glandular-endocrine neoplasm
and has uncommonly been described mostly in the colon. Histologically, this tumor is composed of a predominant
proportion of benign adenomatous component and a small portion of well-differentiated NE component.
Only three cases of NET in gastric adenoma have been reported in the literature. We present 4 cases of NET in
gastric adenoma mimicking invasive adenocarcinoma. The NETs were 0.62 mm to 4.1 mm in size and located at the
basal lamina propria, muscularis mucosa and submucosa. Histologically, NETs consisted of nests, cords, tubules, and
clusters of cells that predominantly interposed between the foveolar base without disturbing the overall polyp
architecture. The lesions were completely removed by endoscopic submucosal dissection in three cases and in one
case, subtotal gastrectomy was performed because endoscopic biopsy was invasive adenocarcinoma. The patients’
clinical course was uneventful without an evidence of recurrence or metastasis. The recognition of NET in gastric
adenoma will help avoid potential diagnostic pitfalls masquerading as invasvie adenocarcinomas posed by their
infiltrative pattern into submucosa.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1688552293761001
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Although localized endocrine cell differentiation in benign
or malignant glandular neoplasms of the gastrointestinal
tract is relatively common, truely mixed glandular-
endocrine neoplasms are rare. These tumors are com-
posed of both glandular component like adenomas and
adenocarcinomas and recognizable neuroendocrine
tumor compoments. Most mixed glandular-endocrine
neoplasms of the stomach are malignant tumors arising in
the background of atrophic gastritis [1-5]. The histologic
spectrum ranges from amphicrine carcinoma to admix-
ture of adenoma or adenocarcinoma with neroendocrine
tumor (NET) or neuroendocrine carcinoma. Only three* Correspondence: kkmkys@skku.edu
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reproduction in any medium, provided the orcases of mixed benign adenoma-NET have been described
in the stomach to date [6-8].
Herein, we describe the clinicopathologic features of
four NETs in association with gastric adenomas, to fur-
ther delineate their histologic features and discuss the
diagnostic pitfalls. Recognition of this rare tumor is im-
portant not only it can be missed easily due to the mi-
nute size of the lesion but also it mimicks an invasive
adenocarcinoma arising from adenoma, which may cause
unnecessary surgery.Case presentation
Clinical summary
Case 1. A 64 year-old man was referred to our hospital
with a 3.8 cm sized polyp in the high body after a
screening upper endoscopy at outside hospital. An ele-
vated polyp was removed in one-piece by endoscopic
submucosal dissection. The patient received a repeat. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Case 2. A 63 year-old man presented with indigestion
and abdominal discomfort. Upper gastrointestinal endos-
copy revealed a 0.5 cm sized elevated nodule in the lesser
curvature of the antrum. The lesion was biopsied initially
and endoscopioc submucosal dissection was done. The
patient repeated upper gastrointestinal endoscopy at one
and two year and no residual lesion was seen.
Case 3. A 52 year-old man was found out to have a
1.5 cm sized polyp in the lower body of the stomach
during staging work up for rectal cancer. The patient
underwent endoscopic submucosal dissection and the le-
sion was completely removed. The resected segment of
rectum revealed a moderately differentiated adenocar-
cinoma and a incidentally found, separately located
0.6 cm sized NET. He received a repeat upper and lower
gastrointestinal endoscopy at two year without any evi-
dence of recurrence.
Case 4. A 65 year-old man with no family hstory of
multiple endocrine neoplasia presented with chronic
dyspepsia. Upper gastrointestinal endoscopy and com-
puted tomography scan revealed a 5 cm sized gastric
mass in the lesser curvature aspect of the body. Initial
endoscopic biopsy diagnosis at the local clinic was well
differentiated adenocarcinoma. He underwent a subtotal
gastrectomy and was found to have a 5.5 cm tubulovil-
lous adenoma. Unexpectedly, small nests of tumor cells
forming a mass infiltrated into the submucosa with an
invasion depth of 800 μm. All sixty regional lymph
nodes procured from the resected specimen were free of
tumor. The patient has no evidence of recurrence or
metastasis during 12 years of follow-up.Histopathology
The histology of all four cases was similar. The clinico-
pathologic details of four cases are listed in Table 1. The
glandular components of four cases were tubular aden-
omas with low- and high-grade dysplasia which consisted
of tubular-shaped glands lined by psuedostratified col-
umnar epithelium with elongated hyperchromatic nuclei




1 64 M Body, PW ESD
2 63 M Body, PW ESD
3 52 M Body, PW ESD
4 65 M Body, LC Subtotal gastrectomy
M indicates male; PW, posterior wall; LC, lesser curvature; ESD, endoscopic submuco
tubular adenoma; TVA, tubulovillous adenoma; AC, adenocarcinoma; NET, neuroendIn all cases, neuroendocrine components represented
only a small portion of the adenoma, which were defined
as NETs. The NETs were located in the lamina propria
and muscularis mucosa in three cases. In one case, the
NET cells infiltrated into the submucosa (Figure 1). All
the NET component of each case consisted of solid nests,
clusters, tubules and cords of cells that predominantly
interposed between the foveolar base without disturbing
the overall polyp architecture. The cells had abundant
eosinophilic granular cytoplasm and cytologically bland,
central and round nuclei with finely stippled chromatin.
Nucleoli were absent or inconspicous and mitotic figures
or necrosis were not observed. Both adenoma and NET
components intermingled and merged together, and in
some areas, both components were difficult to distini-
guish from one another. In the base of polyps, the NET
component appeared to bud off from the basal epithe-
lium of adenoma into the lamina propria (Figure 2). The
transitional zones demonstrated individual polygonal
cells and tiny nests of angulated cells which had enlarged
nuclei with occasional prominent nucleoli and scanty mi-
totic activity. Multiple foci of endocrine cell proliferation
with linear growth pattern were also seen adjacent to the
NETs within the adenomas. The surrounding non-
neoplastic gastric mucosa demonstrated diffuse atrophic
gastritis with intestinal metaplasia. Immunohistochem-
ical studies showed a biphasic staining pattern; the
adenomas were negative for neuroendocrine markers
including synaptophysin, chromogranin and CD56, while
the neuroendocrine components were positive. However,
in the basal part of adenomas, neuroendocrine markers
were focally positive (Figure 3).Discussion
The concept of a mixed adenoma-NET tumor of the
gastrointestinal tract was first introduced by Moyana and
Murphy in 1988 [9]. Mixed glandular-endocrine neo-
plasms in the gastrointestinal tract have been categorized
into three subtypes depending on their predominant pro-
portions of each component by Levin et al.: composite
tumors, collision tumors and amphicrine tumors [10].








0.62 MM TA and NET 2 years
4.0 LP TA and NET 2 years
1.8 MM TA and NET 2 years
4.1 SM TVA with focal AC and NET 12 years
sal dissection; MM, muscularis mucosae; LP, lamina propria; SM, submucosa; TA,
ocrine tumor.
Figure 1 Neuroendocrine tumor with an organoid growth pattern infiltrating into the submucosa within a tubular adenoma (A). Higher
magnification showing small tumor cells in the deeper part of mucosa and submucosa (B).
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roendocrine component is not enough to qualify for at
least one third of the tumor volume, occupying a minute
region of the adenomatous polyp like ours [11]. The size
of NETs in their study ranged from 5 mm to 20 mm.
We report four rare cases of gastric adenomas con-
taining NETs with an infiltrative growth pattern mimick-
ing adenocarcinoma. The most important reason to
recognize NET in a gastric adenoma is to avoid misdiag-
nosis of this rare lesion as an adenocarcinoma arising
from adenoma, which is more common. In our cases,
some areas at the base of a polyp showed an intermix-
ture and mergence of adenomatous glands and neuroen-
docrine cells, which can be misled as tumor cell
pleomophism found in adenocarcinoma. These lesions
appeared to be arisen from the basal epithelium of aden-
omas showing “budding-off” angulated glands and infil-
trated into the muscularis mucosa or submucosa.Figure 2 In the base of polyps, neuroendocrine tumor cells
appeared to bud off from the basal epithelium of
adenomatous glands into the lamina propria with an angulated
glandular appearance..After confirmation of NET in our cases by immuno-
histochemistry, there was an issue to classify the prolif-
eration of the neuroendocrine cells within adenomas
depending on its size and distribution. Until now, no
definite consensus on the histopathologic classification
of proliferative endocrine cell lesion has been estab-
lished. Solcia et al. has proposed the subclassification
based on size, growth pattern, and numbers of endocrine
cells within glands or crypt as follows: simple hyperpla-
sia; linear hyperplasia; micronodular hyperplasia; dyspla-
sia (< 0.5 mm in diameter); NET (> 0.5 mm) [12].
Neuroendocrine components in our cases ranged from
0.62 mm to 4.1 mm. Based on Solcia et al’s classification,
we could define our cases as NET.
The prognosis of benign mixed adenoma-NET of the
stomach can not be completley determined due to the
rarity of cases. Complete removal of an adenoma would
be considered curative whereas the combined NETFigure 3 Immunohistochemistry for chromogranin showing
positive in glands in the lower part of adenoma and
neuroendocrine tumor cells..
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mine the patients’ prognosis. In our four cases, three
cases showed NETs limited in the lamina propria and fo-
cally extended into the muscularis mucosa without any
evidence of local recurrence or metastasis. A large series
by Soga et al. demonstrated that small submucosal NETs
of the stomach had a relatively high metastatic rates
[13]. This study showed that the metastasis in the early-
stage NETs of the stomach is correlated with not only
the submucosal invasion but also the size, which is more
than 10 mm. One of our 4 cases was 4.1 mm in greatest
dimension and showed submucosal invasion. However,
this patient underwent a subtotal gastrectomy and his
sixty regional lymph nodes were free of tumor and no
metastasis has been identified in a long term close
follow-up for 12 years.
Conclusion
In summary, NET may be found in adenomas of the
stomach incidentally, has characteristic morphologic fea-
tures and immunoexpressions as neuroendocrine cells,
and can be under or overdiagnosed due to the small size
of the the lesion and overlapping histology with adeno-
carcinoma. This lesion can be completely treated by
polypectomy or endoscopic resection technique without
recurrence or metastasis. However, if the NET involves
the submucosal layer, close follow-up is recommended
for a relatively higher metastatic rate.
We described four rare cases of NET arising from gas-
tric adenoma and followed benign clinical courses. Rec-
ognition of this rare entity is important for accurate
diagnosis and treatment.
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